Tech Company Financing Transactions
Nephron Pharmaceuticals Funding Round
On 9/18/2023, Nephron Pharmaceuticals secured $350 million in funding from PNC Bank, Blackrock Capital Investment Corporation and National Association of College Stores.
Transaction Overview
Company Name
Announced On
9/18/2023
Transaction Type
Venture Equity
Amount
$350,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support future growth of the pharmaceutical manufacturer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4500 12th Street Extension
West Columbia, SC 29172
USA
West Columbia, SC 29172
USA
Phone
Website
Email Address
Overview
We are proud to be a woman-owned business that leads the world in the manufacturing of generic respiratory medications. The FDA approved our first generic respiratory medication in 1997, and since then we've been committed to bringing safe, effective, and affordable medications to patients in need. Our mission to improve patient outcomes has fueled our commitment to innovation, quality, and service.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lou Kennedy
Chief Marketing Officer
Tim Antal
Chief Technical Officer
Bryan Beck
Browse more venture capital transactions:
Prev: 9/18/2023: Mojave venture capital transaction
Next: 9/18/2023: Series AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs